Clinical outcome of Brazilian patients with non-small cell lung cancer in early stage harboring rare mutations in epidermal growth factor receptor

The common epidermal growth factor receptor (EGFR) mutations, such as the L858R point mutation in exon 21 and the in-frame deletional mutation in exon 19, have been definitively associated with response to EGFR-tyrosine kinase inhibitors (EGFR-TKI). However, the clinical outcome and response to trea...

Popoln opis

Bibliografske podrobnosti

Principais autores:	J. Machado-Rugolo, C.M. Baldavira, T.G. Prieto, E.H.R. Olivieri, A.T. Fabro, C.A. Rainho, E.C. Castelli, P.E.M. Ribolla, A.M. Ab'Saber, T. Takagaki, M.A. Nagai, V.L. Capelozzi
Format:	Artigo
Jezik:	Inglês
Izdano:	Associação Brasileira de Divulgação Científica 2023-01-01
Serija:	Brazilian Journal of Medical and Biological Research
Teme:	Lung cancer Next generation sequencing Rare EGFR mutation Platinum-based chemotherapy Erlotinib
Online dostop:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2022000100687&tlng=en
Oznake:	Označite Brez oznak, prvi označite!